NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,732,000 | +7.0% | 19,800 | 0.0% | 0.75% | +1.9% |
| Q3 2021 | $1,619,000 | -10.4% | 19,800 | 0.0% | 0.74% | -11.6% |
| Q2 2021 | $1,807,000 | +6.7% | 19,800 | 0.0% | 0.83% | -0.7% |
| Q1 2021 | $1,693,000 | -9.5% | 19,800 | 0.0% | 0.84% | -12.8% |
| Q4 2020 | $1,870,000 | +8.6% | 19,800 | 0.0% | 0.96% | -5.5% |
| Q3 2020 | $1,722,000 | -0.4% | 19,800 | 0.0% | 1.02% | -4.5% |
| Q2 2020 | $1,729,000 | +5.9% | 19,800 | 0.0% | 1.07% | -16.7% |
| Q1 2020 | $1,633,000 | -12.9% | 19,800 | 0.0% | 1.28% | +12.2% |
| Q4 2019 | $1,875,000 | +8.9% | 19,800 | 0.0% | 1.14% | +10.1% |
| Q3 2019 | $1,721,000 | -4.8% | 19,800 | 0.0% | 1.04% | +7.0% |
| Q2 2019 | $1,808,000 | -5.0% | 19,800 | 0.0% | 0.97% | -5.7% |
| Q1 2019 | $1,904,000 | +12.1% | 19,800 | 0.0% | 1.03% | -0.5% |
| Q4 2018 | $1,699,000 | -0.4% | 19,800 | 0.0% | 1.03% | +16.0% |
| Q3 2018 | $1,706,000 | +14.0% | 19,800 | 0.0% | 0.89% | -0.1% |
| Q2 2018 | $1,496,000 | – | 19,800 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |